Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Suzanne Malfair"'
Autor:
Greg J. German, Charles Frenette, Jean-Alexandre Caissy, Jennifer Grant, Marie-Astrid Lefebvre, Dominik Mertz, Sarah Lutes, Allison McGeer, Jacqueline Roberts, Kevin Afra, Louis Valiquette, Yannick Émond, Marie Carrier, Anaïs Lauzon-Laurin, Trong Tien Nguyen, Hamed Al-Bachari, Justin Kosar, Shaqil Peermohamed, Michelle Science, Daniel Landry, Timothy MacLaggan, Peter Daley, Gerald McDonald, Anita Ang, Sandra Chang, Yu-Chen Lin, Brandon Tong, Suzanne Malfair, Victor Leung, Kevin Katz, Ines Pauwels, Herman Goossens, Ann Versporten, John Conly, Daniel J.G. Thirion
Publikováno v:
CMAJ Open
Background: Patient-level surveillance of antimicrobial use (AMU) in Canadian hospitals empowers the reduction of inappropriate AMU and was piloted in 2017 among 14 hospitals in Canada. We aimed to describe AMU on the basis of patient-level data in C
Publikováno v:
Nicotine & Tobacco Research. 23:302-309
Introduction The British Columbia Ministry of Health launched a Smoking Cessation Program on September 30, 2011, providing financial coverage for smoking cessation pharmacotherapies. Although pharmacotherapies have been shown to have a moderate short
Autor:
Caitlin Lang, Robin Lee, Alice Hou, Suzanne Malfair, Sukjinder Sidhu, Jordan Schneider, Shu Fei Sophie Liang, Nina Bredenkamp, Adil Virani
Publikováno v:
The Canadian Journal of Hospital Pharmacy. 72
Background: Discharge medication reconciliation (Discharge MedRec) was implemented on one unit at a large urban teaching hospital, and was to be expanded across the rest of the hospital and the health authority’s various sites by the end of 2018. C
Autor:
Susan E. O'Reilly, Caroline Speers, Suzanne Malfair-Taylor, Karen A. Gelmon, Andy Coldman, Ivo A. Olivotto, Yulia D'yachkova, Jeff Barnett, Stephen Chia, Anna Kang
Publikováno v:
Cancer. 110:973-979
Over the past decade, a number of new therapeutic agents have become available in the treatment of metastatic breast cancer (MBC). This study characterized the use and assessed the impact on survival of population-based access to new agents for the t